Showing 1 - 12 results of 12 for search 'Caroline M. Tanner', query time: 0.05s
Refine Results
-
1
-
2
Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia by Rajesh Pahwa, Susan Fox, Robert A. Hauser, Stuart Isaacson, Judy Lytle, Reed Johnson, Lily Llorens, Andrea E. Formella, Caroline M. Tanner
Published 2022-10-01
Article -
3
Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study by Caroline M. Tanner, Stanley N. Caroff, Andrew J. Cutler, William R. Lenderking, Huda Shalhoub, Véronique Pagé, Ericha G. Franey, Michael Serbin, Chuck Yonan
Published 2023-03-01
Article -
4
Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform by Ethan G Brown, Erica Schleimer, Ian O Bledsoe, William Rowles, Nicolette A Miller, Stephan J Sanders, Katherine P Rankin, Jill L Ostrem, Caroline M Tanner, Riley Bove
Published 2022-05-01
Article -
5
Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. by Chuong B Do, Joyce Y Tung, Elizabeth Dorfman, Amy K Kiefer, Emily M Drabant, Uta Francke, Joanna L Mountain, Samuel M Goldman, Caroline M Tanner, J William Langston, Anne Wojcicki, Nicholas Eriksson
Published 2011-06-01
Article -
6
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram by Ibrahim Karabayir, Fatma Gunturkun, Liam Butler, Samuel M. Goldman, Rishikesan Kamaleswaran, Robert L. Davis, Kalea Colletta, Lokesh Chinthala, John L. Jefferies, Kathleen Bobay, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Caroline M. Tanner, Oguz Akbilgic
Published 2023-07-01
Article -
7
Video-based Parkinson’s disease assessments in a nationwide cohort of Fox Insight participants by Taylor L. Myers, Christopher G. Tarolli, Jamie L. Adams, Richard Barbano, María Cristina Gil-Díaz, Kelsey L. Spear, Jill Lowell, Margaret Daeschler, Lindsey Riley, Ninad Amondikar, Peggy Auinger, Connie Marras, Caroline M. Tanner, E. Ray Dorsey, Ruth B. Schneider
Published 2021-01-01
Article -
8
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism by Caroline M. Tanner, Steven R. Cummings, Michael A. Schwarzschild, Ethan G. Brown, E. Ray Dorsey, Alberto J. Espay, Nicholas B. Galifianakis, Samuel M. Goldman, Irene Litvan, Nijee Luthra, Nikolaus R. McFarland, Kyle T. Mitchell, David G. Standaert, Douglas C. Bauer, Susan L. Greenspan, James C. Beck, Kenneth W. Lyles
Published 2021-03-01
Article -
9
A high-density genome-wide association screen of sporadic ALS in US veterans. by Lydia Coulter Kwee, Yutao Liu, Carol Haynes, Jason R Gibson, Annjanette Stone, Steven A Schichman, Freya Kamel, Lorene M Nelson, Barbara Topol, Stephen K Van den Eeden, Caroline M Tanner, Merit E Cudkowicz, Daniela L Grasso, Robert Lawson, Sumitra Muralidhar, Eugene Z Oddone, Silke Schmidt, Michael A Hauser
Published 2012-01-01
Article -
10
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP) by Andrea Sturchio, Luca Marsili, Joaquin A. Vizcarra, Alok K. Dwivedi, Marcelo A. Kauffman, Marcelo A. Kauffman, Andrew P. Duker, Peixin Lu, Peixin Lu, Michael W. Pauciulo, Benjamin D. Wissel, Benjamin D. Wissel, Emily J. Hill, Benjamin Stecher, Elizabeth G. Keeling, Achala S. Vagal, Lily Wang, David B. Haslam, Matthew J. Robson, Caroline M. Tanner, Daniel W. Hagey, Samir El Andaloussi, Kariem Ezzat, Ronan M. T. Fleming, Long J. Lu, Max A. Little, Max A. Little, Alberto J. Espay
Published 2020-10-01
Article -
11
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts by Tien Dam, Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub, Lana M. Chahine, Christopher Coffey, Caroline M. Tanner, Catherine M. Kopil, Yuge Xiao, Sohini Chowdhury, Luis Concha-Marambio, Peter DiBiaso, Tatiana Foroud, Mark Frasier, Danna Jennings, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Thomas J. Montine, Kelly Nudelman, John Seibyl, Todd Sherer, Andrew Singleton, Diane Stephenson, Matthew Stern, Claudio Soto, Eduardo Tolosa, Andrew Siderowf, Billy Dunn, Tanya Simuni, Kenneth Marek, the Parkinson’s Progression Markers Initiative
Published 2024-09-01
Article -
12
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial by Charity G. Patterson, Elizabeth Joslin, Alexandra B. Gil, Wendy Spigle, Todd Nemet, Lana Chahine, Cory L. Christiansen, Ed Melanson, Wendy M. Kohrt, Martina Mancini, Deborah Josbeno, Katherine Balfany, Garett Griffith, Mac Kenzie Dunlap, Guillaume Lamotte, Erin Suttman, Danielle Larson, Chantale Branson, Kathleen E. McKee, Li Goelz, Cynthia Poon, Barbara Tilley, Un Jung Kang, Malú Gámez Tansey, Nijee Luthra, Caroline M. Tanner, Jacob M. Haus, Giamila Fantuzzi, Nikolaus R. McFarland, Paulina Gonzalez-Latapi, Tatiana Foroud, Robert Motl, Michael A. Schwarzschild, Tanya Simuni, Kenneth Marek, Anna Naito, Codrin Lungu, Daniel M. Corcos, The SPARX3-PSG Investigators
Published 2022-10-01
Article